Australia: Myriad Genetics Owns Trademark for 'MYRISK HEREDITARY CANCER TEST' and 'BOX'

Australia, Aug. 26 -- Myriad Genetics Inc., owns the trademark (2546547) for 'MYRISK HEREDITARY CANCER TEST' and 'BOX' till May 9, 2035.

Status: registered: Registered/protected

Classes: 10 [Medical test kits comprising specimen collection tubes and containers for collecting patient specimens along with printed test forms, mailing materials, and printed user information inserts for use in detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease] and 10 [Medical test kits comprising specimen collection tubes and containers for collecting patient specimens along with printed test forms, mailing materials, and printed user information inserts for use in detection of gene mutations, gene expression profiles or other molecular indicators or markers associated with disease or risk of developing disease]

Type of Mark: Figurative

Date of Acceptance: May 20

Registration Advertised: Aug. 25

For further details contact Davies Collison Cave Pty. Ltd. .

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2546547.

Disclaimer: Curated by HT Syndication.